A dose–response study of intravenous regional analgesia with lidocaine in rabbits

By Ganidagli Suleyman   Biricik Halil Selcuk   Cengiz Mustafa   Kilic Halil Ibrahim   Erdogan Nadir  

The Pain Clinic, Vol. 16, Iss. 1, 2004-06 ,pp. : 71-76

Maney Publishing

Access to resources Recommend Favorite

A Randomised Study to Determine Whether Routine Intravenous Magnesium Supplements are Necessary in Patients Receiving Cisplatin Chemotherapy with Continuous Infusion 5-Fluorouracil

By Evans T.R.J.   Harper C.L.   Beveridge I.G.   Wastnage R.   Mansi J.L.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 174-178

Elsevier

Access to resources Recommend Favorite

Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy

By              

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 7039-7044

Spandidos Publications

Access to resources Recommend Favorite

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors

By Murakami H.   Kurata T.   Onozawa Y.   Watanabe J.   Ono A.   Takahashi T.   Yamamoto N.   Fujisaka Y.   Kiyota H.   Hayashi H.   Tanaka K.   Nakagawa K.   Kuroda S.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 623-630

Springer Publishing Company

Access to resources Recommend Favorite

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

By Oster Gerry   Lamerato Lois   Glass Andrew   Richert-Boe Kathryn   Lopez Andrea   Chung Karen   Richhariya Akshara   Dodge Tracy   Wolff Greg   Balakumaran Arun   Edelsberg John  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1363-1373

Springer Publishing Company

Access to resources Recommend Favorite